Terms ending in 2033
Every in-force patent on Biodesix, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,467,988 | Method and System for Validation of Mass Spectrometer Machine Performance In force · High confidence | Biodesix, Inc. | In force | High confidence | |
| US 9,403,889 | Diagnostic Lung Cancer Panel and Methods for Its Use In force · High confidence | Biodesix, Inc. | In force | High confidence | |
| US 11,467,167 | SRM Methods in Alzheimer's Disease and Neurological Disease Assays In force · Medium confidence | Biodesix, Inc. | In force | Medium confidence | |
| US 9,279,798 | Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof In force · High confidence | Biodesix, Inc. | In force | High confidence | |
| US 9,606,101 | Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof In force · High confidence | Biodesix, Inc. | In force | High confidence | |
| US 9,201,044 | Compositions, Methods and Kits for Diagnosis of Lung Cancer In force · High confidence | Biodesix, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.